Coinfections and antimicrobial use in patients hospitalized with coronavirus disease 2019 (COVID-19) across a single healthcare system in New York City: A retrospective cohort study.

ABSTRACT:

Background and objective

With the coronavirus disease 2019 (COVID-19) pandemic, rates of in-hospital antimicrobial use increased due to perceived bacterial and fungal coinfections along with COVID-19. We describe the incidence of these coinfections and antimicrobial use in patients hospitalized with COVID-19 to help guide effective antimicrobial use in this population.

Setting

This study was conducted in 3 tertiary-care referral university teaching hospitals in New York City.

Methods

This multicenter retrospective observational cohort study involved all patients admitted with COVID-19 from January 1, 2020, to February 1, 2021. Variables of interest were extracted from a de-identified data set of all COVID-19 infections across the health system. Population statistics a

SUBMITTER: Prasad PJ 

PROVIDER: S-EPMC9726479 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature